Urine collection device ישראל - עברית - Ministry of Health

urine collection device

e.z.l packaging ltd - כלל האוכלוסיה - כלי לאיסוף שתן

Anchor Fast Oral Endotracheal Tube Fastener ישראל - עברית - Ministry of Health

anchor fast oral endotracheal tube fastener

קיור מדיקל אנד טכניקל סופלאי - רופא - to hold an oral endotracheal tube securely in place

יאז פלוס ישראל - עברית - Ministry of Health

יאז פלוס

bayer israel ltd - drospirenone; ethinylestradiol as betadex clathrate; levomefolate calcium; levomefolate calcium - טבליות מצופות פילם - levomefolate calcium 0.451 mg; ethinylestradiol as betadex clathrate 0.02 mg; drospirenone 3 mg; levomefolate calcium 0.451 mg - estradiol, combinations

ג'נס ישראל - עברית - Ministry of Health

ג'נס

bayer israel ltd - levonorgestrel - levonorgestrel 13.5 mg - levonorgestrel

ג'נס ישראל - עברית - Ministry of Health

ג'נס

bayer israel ltd - levonorgestrel - levonorgestrel 13.5 mg - levonorgestrel

פרימולוט-נור ישראל - עברית - Ministry of Health

פרימולוט-נור

bayer israel ltd - norethisterone acetate - טבליה - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.

ויזאבל ישראל - עברית - Ministry of Health

ויזאבל

bayer israel ltd - dienogest - טבליה - dienogest 2 mg - dienogest and estrogen - dienogest and estrogen - treatment of endometriosis.

פרוגילוטון ישראל - עברית - Ministry of Health

פרוגילוטון

bayer israel ltd - estradiol valerate; estradiol valerate; norgestrel - טבליה - estradiol valerate 2 mg; norgestrel 0.5 mg; estradiol valerate 2 mg - norgestrel and estrogen - norgestrel and estrogen - two phase preparation for climacteric and cycle disturbances.

גאמאגארד S/D אימונוגלובולין תוך ורידי 2.5 גר' ישראל - עברית - Ministry of Health

גאמאגארד s/d אימונוגלובולין תוך ורידי 2.5 גר'

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation

גאמאגארד S/D אימונוגלובולין תוך ורידי 5 גר' ישראל - עברית - Ministry of Health

גאמאגארד s/d אימונוגלובולין תוך ורידי 5 גר'

teva medical marketing ltd. - immunoglobulin normal human 50 mg/ml - powder for solution for injection - immunoglobulins, normal human, for intravascular adm. - replacement therapy in:• primary immunodeficiency syndromes (pid) such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia; - common variable immunodeficiency; - severe combined immunodeficiency; - wiskott aldrich syndrome.• myeloma or chronic lymphocytic leukaemia (cll) with severe secondary hypogammaglobulinaemia and recurrent infections.• children with congenital aids and recurrent infections.immunomodulation• idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.• guillain barr? syndrome. in this case gammagard s/d (solvent/detergent) is only indicated in patients showing one of the following symptoms: - progressive paresis (the patient cannot walk more than 10 m on his own); - signs of a respiratory disorder (clinically observed or demonstrated by measuring the vital capacity at the patient’s bed); - signs of oropharyngeal paresis.• kawasaki disease.allogeneic bone marrow transplantation